The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -72.46%.However, over the last six months, we can see a stronger performance of -30.82%. Over the last 30 days, the price of CGTX has fallen by 80.70%. And in the last five days, it has surged by 40.10%.
At present, Cognition Therapeutics Inc (CGTX) has a stock price of $0.57. In the previous session, the stock saw a rise, peaking at $4.0 after an opening price of $0.57. The day’s lowest price was $2.0, and it closed at $0.7.
Cognition Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $2.54 on 07/26/24 and a low of $0.22 for the same time frame on 05/28/25.
52-week price history of CGTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Cognition Therapeutics Inc’s current trading price is -77.62% away from its 52-week high, while its distance from the 52-week low is 155.24%. The stock’s price range during this period has varied between$0.22 and $2.54. The Cognition Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 9.03 million for the day, a figure considerably higher than their average daily volume of 6.32 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Cognition Therapeutics Inc (CGTX) has experienced a quarterly rise of 73.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 35.17M and boasts a workforce of 28 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3901, with a change in price of -0.0227. Similarly, Cognition Therapeutics Inc recorded 4,639,570 in trading volume during the last 100 days, posting a change of -3.85%.
CGTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CGTX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.02.
CGTX Stock Stochastic Average
As of today, Cognition Therapeutics Inc’s raw stochastic average for the last 50 days stands at 42.20%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 40.18%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 56.81% and 71.53%, respectively.
